254 related articles for article (PubMed ID: 20194765)
1. Seromic profiling of ovarian and pancreatic cancer.
Gnjatic S; Ritter E; Büchler MW; Giese NA; Brors B; Frei C; Murray A; Halama N; Zörnig I; Chen YT; Andrews C; Ritter G; Old LJ; Odunsi K; Jäger D
Proc Natl Acad Sci U S A; 2010 Mar; 107(11):5088-93. PubMed ID: 20194765
[TBL] [Abstract][Full Text] [Related]
2. Using protein microarray to identify and evaluate autoantibodies to tumor-associated antigens in ovarian cancer.
Ma Y; Wang X; Qiu C; Qin J; Wang K; Sun G; Jiang D; Li J; Wang L; Shi J; Wang P; Ye H; Dai L; Jiang BH; Zhang J
Cancer Sci; 2021 Feb; 112(2):537-549. PubMed ID: 33185955
[TBL] [Abstract][Full Text] [Related]
3. Proteomic mapping of p53 immunogenicity in pancreatic, ovarian, and breast cancers.
Katchman BA; Barderas R; Alam R; Chowell D; Field MS; Esserman LJ; Wallstrom G; LaBaer J; Cramer DW; Hollingsworth MA; Anderson KS
Proteomics Clin Appl; 2016 Jul; 10(7):720-31. PubMed ID: 27121307
[TBL] [Abstract][Full Text] [Related]
4. Identifying novel autoantibody signatures in ovarian cancer using high-density protein microarrays.
Gunawardana CG; Memari N; Diamandis EP
Clin Biochem; 2009 Mar; 42(4-5):426-9. PubMed ID: 19094976
[TBL] [Abstract][Full Text] [Related]
5. Seromic analysis of antibody responses in non-small cell lung cancer patients and healthy donors using conformational protein arrays.
Gnjatic S; Wheeler C; Ebner M; Ritter E; Murray A; Altorki NK; Ferrara CA; Hepburne-Scott H; Joyce S; Koopman J; McAndrew MB; Workman N; Ritter G; Fallon R; Old LJ
J Immunol Methods; 2009 Feb; 341(1-2):50-8. PubMed ID: 19041653
[TBL] [Abstract][Full Text] [Related]
6. The identification of phosphoglycerate kinase-1 and histone H4 autoantibodies in pancreatic cancer patient serum using a natural protein microarray.
Patwa TH; Li C; Poisson LM; Kim HY; Pal M; Ghosh D; Simeone DM; Lubman DM
Electrophoresis; 2009 Jun; 30(12):2215-26. PubMed ID: 19582723
[TBL] [Abstract][Full Text] [Related]
7. Application of protein microarrays for multiplexed detection of antibodies to tumor antigens in breast cancer.
Anderson KS; Ramachandran N; Wong J; Raphael JV; Hainsworth E; Demirkan G; Cramer D; Aronzon D; Hodi FS; Harris L; Logvinenko T; LaBaer J
J Proteome Res; 2008 Apr; 7(4):1490-9. PubMed ID: 18311903
[TBL] [Abstract][Full Text] [Related]
8. Autoantibody biomarkers for the detection of serous ovarian cancer.
Katchman BA; Chowell D; Wallstrom G; Vitonis AF; LaBaer J; Cramer DW; Anderson KS
Gynecol Oncol; 2017 Jul; 146(1):129-136. PubMed ID: 28427776
[TBL] [Abstract][Full Text] [Related]
9. Cancer biomarkers defined by autoantibody signatures to aberrant O-glycopeptide epitopes.
Wandall HH; Blixt O; Tarp MA; Pedersen JW; Bennett EP; Mandel U; Ragupathi G; Livingston PO; Hollingsworth MA; Taylor-Papadimitriou J; Burchell J; Clausen H
Cancer Res; 2010 Feb; 70(4):1306-13. PubMed ID: 20124478
[TBL] [Abstract][Full Text] [Related]
10. Humoral autoimmune responses to insulin-like growth factor II mRNA-binding proteins IMP1 and p62/IMP2 in ovarian cancer.
Liu X; Ye H; Li L; Li W; Zhang Y; Zhang JY
J Immunol Res; 2014; 2014():326593. PubMed ID: 24872956
[TBL] [Abstract][Full Text] [Related]
11. Novel Autoantibody Signatures in Sera of Patients with Pancreatic Cancer, Chronic Pancreatitis and Autoimmune Pancreatitis: A Protein Microarray Profiling Approach.
Ghassem-Zadeh S; Hufnagel K; Bauer A; Frossard JL; Yoshida M; Kutsumi H; Acha-Orbea H; Neulinger-Muñoz M; Vey J; Eckert C; Strobel O; Hoheisel JD; Felix K
Int J Mol Sci; 2020 Mar; 21(7):. PubMed ID: 32244327
[TBL] [Abstract][Full Text] [Related]
12. Serological proteome analysis approach-based identification of ENO1 as a tumor-associated antigen and its autoantibody could enhance the sensitivity of CEA and CYFRA 21-1 in the detection of non-small cell lung cancer.
Dai L; Qu Y; Li J; Wang X; Wang K; Wang P; Jiang BH; Zhang J
Oncotarget; 2017 May; 8(22):36664-36673. PubMed ID: 28456790
[TBL] [Abstract][Full Text] [Related]
13. Development of a novel multiplex beads-based assay for autoantibody detection for colorectal cancer diagnosis.
Villar-Vázquez R; Padilla G; Fernández-Aceñero MJ; Suárez A; Fuente E; Pastor C; Calero M; Barderas R; Casal JI
Proteomics; 2016 Apr; 16(8):1280-90. PubMed ID: 26915739
[TBL] [Abstract][Full Text] [Related]
14. Discovery and Validation of Serum Autoantibodies Against Tumor-Associated Antigens as Biomarkers in Gastric Adenocarcinoma Based on the Focused Protein Arrays.
Yang Q; Qin J; Sun G; Qiu C; Jiang D; Ye H; Wang X; Dai L; Zhu J; Wang P; Zhang J
Clin Transl Gastroenterol; 2020 Dec; 12(1):e00284. PubMed ID: 33346593
[TBL] [Abstract][Full Text] [Related]
15. Autoantibodies to MUC1 glycopeptides cannot be used as a screening assay for early detection of breast, ovarian, lung or pancreatic cancer.
Burford B; Gentry-Maharaj A; Graham R; Allen D; Pedersen JW; Nudelman AS; Blixt O; Fourkala EO; Bueti D; Dawnay A; Ford J; Desai R; David L; Trinder P; Acres B; Schwientek T; Gammerman A; Reis CA; Silva L; Osório H; Hallett R; Wandall HH; Mandel U; Hollingsworth MA; Jacobs I; Fentiman I; Clausen H; Taylor-Papadimitriou J; Menon U; Burchell JM
Br J Cancer; 2013 May; 108(10):2045-55. PubMed ID: 23652307
[TBL] [Abstract][Full Text] [Related]
16. Serum autoantibodies against a panel of 15 tumor-associated antigens in the detection of ovarian cancer.
Sun H; Shi JX; Zhang HF; Xing MT; Li P; Dai LP; Luo CL; Wang X; Wang P; Ye H; Li LX; Zhang JY
Tumour Biol; 2017 Jun; 39(6):1010428317699132. PubMed ID: 28618923
[TBL] [Abstract][Full Text] [Related]
17. Cancer-associated autoantibodies to MUC1 and MUC4--a blinded case–control study of colorectal cancer in UK collaborative trial of ovarian cancer screening.
Pedersen JW; Gentry-Maharaj A; Nøstdal A; Fourkala EO; Dawnay A; Burnell M; Zaikin A; Burchell J; Papadimitriou JT; Clausen H; Jacobs I; Menon U; Wandall HH
Int J Cancer; 2014 May; 134(9):2180-88. PubMed ID: 24122770
[TBL] [Abstract][Full Text] [Related]
18. [Clinical study of autoantibody spectrum against ovarian cancer associated antigens combined with CA(125) in detecting and monitoring ovarian cancer].
Yang ZJ; Yang G; Jiang YM; Ran YL; Yang ZH; Zhang W; Zhang JQ; Pan ZM; Li L
Zhonghua Fu Chan Ke Za Zhi; 2011 Feb; 46(2):113-8. PubMed ID: 21426769
[TBL] [Abstract][Full Text] [Related]
19. Immunodiagnostic value of combined detection of autoantibodies to tumor-associated antigens as biomarkers in pancreatic cancer.
Li J; Wang LJ; Ying X; Han SX; Bai E; Zhang Y; Zhu Q
Scand J Immunol; 2012 Mar; 75(3):342-9. PubMed ID: 22010875
[TBL] [Abstract][Full Text] [Related]
20. Patient-derived tumor-reactive antibodies as diagnostic markers for ovarian cancer.
Taylor DD; Gercel-Taylor C; Parker LP
Gynecol Oncol; 2009 Oct; 115(1):112-120. PubMed ID: 19647308
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]